This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
PRB3 Polyclonal Antibody
catalog :
PA5-45732
quantity :
100 uL
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Product Type :
Antibody
Product Name :
PRB3 Polyclonal Antibody
Catalog # :
PA5-45732
Quantity :
100 uL
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Affinity Chromatography
Host :
Rabbit
Reactivity :
Human
Applications :
Western Blot: 1 ug/mL
Species :
Human
Isotype :
IgG
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
PRB3 protein is identical to the gross cystic disease fluid protein GCDFP-15, secretory actin binding protein (SABP) and glycoprotein 17 (GP-17). GCDFP-15 is expressed by breast carcinomas (primary and metastatic lesions) with apocrine features.
Immunogen :
Synthetic peptide directed towards the middle region of human PRB3
Format :
Liquid
Applications w/Dilutions :
Western Blot: 1 ug/mL
Aliases :
basic salivary proline-rich protein 3; BstNI type basic salivary proline-rich protein 3; G1; G1 parotid salivary glycoprotein; MGC116862; MGC116863; MGC116864; parotid salivary glycoprotein G1; PRB3; PRG; proline rich 21; proline rich protein BstNI subfamily 3; proline-rich glycoprotein (sgp158); proline-rich protein BstNI subfamily 3; proline-rich protein G1; Prr21; Sgp158
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments